What is Eczema?
Eczema is a chronic inflammatory skin condition, characterized by dry skin with red and itchy patches. Atopic dermatitis (AD) is the most common type of eczema. The word “atopic” refers to a collection of diseases involving the immune system, and the word “dermatitis” means inflammation of the skin. Eczema can range from mild, when patches of skin are slightly dry, itchy, and red, to severe, when patches of skin are extremely irritated, cracked, and oozing. Eczema most often develops in childhood and may or may not continue into adulthood. People with eczema often experience periods of time when their condition flares up, often triggered by environmental factors such as the weather, certain foods, stress, hormones, irritants, and allergens.
- Topical corticosteroids
- Oral steroids
- Topical calcineurin inhibitors
- Antibiotics to treat secondary skin infections
- Moisturizers and emollients
- Coal tar
We currently do not have any recruiting eczema clinical trials. Please contact us to be placed on a contact list for our next available clinical trial
Sponsor: ANAPTYSBIO INC.
A randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study investigating the efficacy, safety, and pharmacokinetic profile of ANB020 administered to adult subjects with moderate-to-severe atopic dermatitis
- Age 18 to 75 years
- Moderate to severe eczema
- 16 weeks of treatment with ANB020 injections (150 mg monthly, 150 mg every 2 months, or 300 mg monthly) or placebo injections
- Approximately 11 clinic visits over a period of about 24 weeks